Watermark
  Back to Search Results

BGB-A317-316

Not yet recruiting

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Ask to Join

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-316

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT07043400

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2025-522862-58-00

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents